• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Spero Therapeutics Inc (NQ: SPRO )

    1.305 +0.025 (+1.95%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 2, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 34,442
    Open 1.280
    Bid (Size) 1.300 (57)
    Ask (Size) 1.310 (72)
    Prev. Close 1.280
    Today's Range 1.280 - 1.310
    52wk Range 0.9900 - 1.890
    Shares Outstanding 52,571,813
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    SPRO Stock Earnings: Spero Therapeutics Misses EPS, Misses Revenue for Q1 2024
    SPRO stock results show that Spero Therapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
    Via InvestorPlace
    Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Shares of Limbach Holdings, Inc. (NASDAQ: LMB) fell sharply during Thursday’s session after the company reported fourth-quarter financial results and issued FY24 revenue guidance below estimates. 
    Via Benzinga

    Performance

    YTD
    -14.14%
    -14.14%
    1 Month
    -8.74%
    -8.74%
    3 Month
    -27.09%
    -27.09%
    6 Month
    -14.14%
    -14.14%
    1 Year
    -11.22%
    -11.22%

    More News

    Read More
    Why Robinhood Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Recap: Spero Therapeutics Q4 Earnings
    Via Benzinga
    Earnings Outlook For Spero Therapeutics
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    Via InvestorPlace
    Earnings Scheduled For March 13, 2024
    Via Benzinga
    Recap: Spero Therapeutics Q3 Earnings
    Via Benzinga
    Earnings Outlook For Spero Therapeutics
    Via Benzinga
    4 Analysts Have This to Say About Spero Therapeutics
    Via Benzinga
    5 Value Stocks In The Healthcare Sector
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    SPERO ALERT: Bragar Eagel & Squire, P.C. is Investigating Spero Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire, P.C.
    Via Business Wire
    Spero Therapeutics's Earnings: A Preview
    Via Benzinga
    Recap: Spero Therapeutics Q1 Earnings
    Via Benzinga
    Spero Therapeutics's Earnings Outlook
    Via Benzinga
    Spero Therapeutics's Earnings: A Preview
    Via Benzinga
    Earnings Scheduled For November 13, 2023
    Via Benzinga
    Overview Of Value Stocks In The Healthcare Sector
    Via Benzinga
    HC Wainwright & Co. Maintains Buy Rating for Spero Therapeutics: Here's What You Need To Know
    Via Benzinga
    Earnings Scheduled For May 11, 2023
    Via Benzinga
    Earnings Scheduled For August 10, 2023
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    Via InvestorPlace
    Earnings Scheduled For March 30, 2023
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.